Michele Cottler‐Fox

High Impact

Professor

University of Arkansas for Medical Sciences

faculty

42 h-index 208 pubs 6,627 cited

Research Areas

Multiple Myeloma Research and Treatments Hematopoietic Stem Cell Transplantation CAR-T cell therapy research Platelet Disorders and Treatments Maternal and Perinatal Health Interventions Healthcare Policy and Management Cancer Treatment and Pharmacology

Links

ORCID Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Michele Cottler‐Fox is a researcher at the University of Arkansas for Medical Sciences. Her work focuses on hematology and stem cell transplantation, with recent publications examining maintenance therapy with Velcade, Revlimid, and Dexamethasone (VRD) in multiple myeloma and the impact of new hematopoietic progenitor cell (HPC) collection goals on apheresis and cell therapy laboratory services. Cottler‐Fox has also investigated the use of autologous HPC boosts after chimeric antigen receptor T-cell (CAR-T) therapy and the association of HLA-DR-DQ with acquired thrombotic thrombocytopenic purpura (aTTP).

Her research group has explored strategies to overcome adverse metaphase cytogenetics in fractionated melphalan transplants by adding bortezomib and thalidomide. Additionally, Cottler‐Fox has contributed to understanding barriers and facilitators to cord blood banking among pregnant women. Her scholarship metrics include an h-index of 42, with over 208 publications and 6,627 citations. She is recognized as a highly cited researcher and collaborates with colleagues including Clyde Bailey, Susan Panozzo, Shmuel Yaccoby, and Erming Tian at the University of Arkansas for Medical Sciences.

Metrics

h-index: 42
Publications: 208
Citations: 6,627

Selected Publications

Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services (2025) DOI
SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB (2024) DOI
HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies (2024) DOI
Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up (2023) DOI
Barriers and facilitators to cord blood banking among pregnant women at a university obstetric clinic (2023) DOI